Article | November 1, 2021

Eight Technological "Must Haves" To Support Your Decentralized Clinical Trial

Science technology concept Laboratory Examination Research iStock-1180547351

Over the past decade, there has been a gradual uptick in the popularity of decentralized clinical trials (DCTs)—a trend that has accelerated dramatically due to Covid-19. Now, there will be no going back, largely for patients. “Patient-centricity” is more than an industry buzzword; it is a form of enlightened self-interest for sponsors and researchers. By minimizing the burden of participating in a clinical trial, sponsors simplify recruitment and increase retention and compliance. Study effectiveness is amplified and drugs get to market faster, saving patient lives and sponsor money.

 

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: